|
gptkb:Intas_Pharmaceuticals_Australia
|
Phase I Trials
|
|
gptkb:Blu-U
|
2-3 times per week
|
|
gptkb:Golodirsen
|
Phase 1, Phase 2
|
|
gptkb:AcrySof_Natural
|
followed
|
|
gptkb:Oklahoma_State_University_College_of_Pharmacy
|
Various_Hospitals_and_Clinics
|
|
gptkb:Guru_Gobind_Singh_Medical_College
|
Yes
|
|
gptkb:Monica_M._Bertagnolli
|
Phase II trials
|
|
gptkb:K._P._Rahul
|
5
|
|
gptkb:Elan_Pharmaceuticals
|
completed studies for existing therapies
|
|
gptkb:Panadol
|
pain from shingles
|
|
gptkb:USH2A_protein
|
various trials in progress
|
|
gptkb:GenSight_Biologics
|
gptkb:Slovenia
|
|
gptkb:Argentine_National_Congress
|
true
|
|
gptkb:TearScience
|
improved satisfaction
|
|
gptkb:Eagle_Pharmaceuticals
|
Conducts Phase I clinical trials
|
|
gptkb:Medtronic_plc
|
conducts clinical research studies
|
|
gptkb:Michael_A._Maron
|
Cardiovascular health education
|
|
gptkb:Rexulti
|
Phase III
|
|
gptkb:Dr._Paul_Roth
|
Improved Patient Outcomes
|
|
gptkb:Siachen_Brigade
|
helicopter evacuations
|